(Q36799687)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17454264%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

review article

1 reference

title

Regulation of type 1 diabetes by NKT cells (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17454264%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

0 references

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17454264%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Jan Novak

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17454264%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Thibault Griseri

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17454264%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Lucie Beaudoin

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17454264%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

publication date

1 January 2007

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17454264%20AND%20SRC:MED&resulttype=core&format=json

International Reviews of Immunology

29 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17454264%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17454264%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

page(s)

49-72

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17454264%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17454264%20AND%20SRC:MED&resulttype=core&format=json

Type 1 diabetes: new perspectives on disease pathogenesis and treatment

29 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Genetic susceptibility to type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

The NOD mouse: a model of immune dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Opinion: Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Mouse CD1-specific NK1 T cells: development, specificity, and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

CD1: antigen presentation and T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Janus-like role of regulatory iNKT cells in autoimmune disease and tumour immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Going both ways: immune regulation via CD1d-dependent NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Overexpression of natural killer T cells protects Valpha14- Jalpha281 transgenic nonobese diabetic mice against diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

A defect in interleukin 12-induced activation and interferon gamma secretion of peripheral natural killer T cells in nonobese diabetic mice suggests new pathogenic mechanisms for insulin-dependent diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

alpha/beta-T cell receptor (TCR)+CD4-CD8- (NKT) thymocytes prevent insulin-dependent diabetes mellitus in nonobese diabetic (NOD)/Lt mice by the influence of interleukin (IL)-4 and/or IL-10.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

CD1-restricted NK T cells protect nonobese diabetic mice from developing diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Interleukin-4 but not interleukin-10 protects against spontaneous and recurrent type 1 diabetes by activated CD1d-restricted invariant natural killer T-cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Valpha14 NK T cell-triggered IFN-gamma production by Gr-1+CD11b+ cells mediates early graft loss of syngeneic transplanted islets.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Synthetic glycolipid OCH prevents insulitis and diabetes in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Role of regulatory invariant CD1d-restricted natural killer T-cells in protection against type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

CD1d-restricted help to B cells by human invariant natural killer T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Signaling through OX40 (CD134) breaks peripheral T-cell tolerance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

The natural killer T (NKT) cell ligand alpha-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Activation of natural killer T cells by alpha-galactosylceramide rapidly induces the full maturation of dendritic cells in vivo and thereby acts as an adjuvant for combined CD4 and CD8 T cell immunity to a coadministered protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Preferential T(h)2 polarization by OCH is supported by incompetent NKT cell induction of CD40L and following production of inflammatory cytokines by bystander cells in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Dendritic cell maturation is required for the cross-tolerization of CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

CD1-reactive natural killer T cells are required for development of systemic tolerance through an immune-privileged site.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Autoreactive CD8 T cells in organ-specific autoimmunity: emerging targets for therapeutic intervention.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Activation of natural killer T cells potentiates or prevents experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Natural killer T cell activation protects mice against experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Cutting edge: V alpha 14-J alpha 281 NKT cells naturally regulate experimental autoimmune encephalomyelitis in nonobese diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Distinct functional lineages of human V(alpha)24 natural killer T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Functionally distinct subsets of CD1d-restricted natural killer T cells revealed by CD1d tetramer staining

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

In vivo identification of glycolipid antigen-specific T cells using fluorescent CD1d tetramers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Transforming growth factor-beta production and myeloid cells are an effector mechanism through which CD1d-restricted T cells block cytotoxic T lymphocyte-mediated tumor immunosurveillance: abrogation prevents tumor recurrence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Differential antitumor immunity mediated by NKT cell subsets in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

CD1-restricted CD4+ T cells in major histocompatibility complex class II-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Surface receptors identify mouse NK1.1+ T cell subsets distinguished by function and T cell receptor type

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Extreme Th1 bias of invariant Valpha24JalphaQ T cells in type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Multiple differences in gene expression in regulatory Valpha 24Jalpha Q T cells from identical twins discordant for type I diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Multiple immuno-regulatory defects in type-1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Therapeutic manipulation of iNKT cells in autoimmunity: modes of action and potential risks.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Immunoregulatory T cells in tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Prevention of autoimmunity by targeting a distinct, noninvariant CD1d-reactive T cell population reactive to sulfatide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229

Therapeutic activation of Vα24+Vβ11+ NKT cells in human subjects results in highly coordinated secondary activation of acquired and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180601070229